Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Coffee and tea might help hair growth in balding individuals, but side effects and alternative uses are being considered.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Finasteride affects the male rat brain by reducing certain protein activation, but these effects may reverse after stopping the drug.

A patient produced cortisol after adrenalectomy, possibly due to residual tissue or other body parts making steroids.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

A man with severe hair loss regrew hair after hormone treatment.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

New treatments for male hypogonadism are effective and should be personalized.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Children with trichotillomania often pull hair from their scalp, and parents may not notice; stress can trigger it, and asking detailed questions helps in diagnosis and treatment.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Both genetic and lifestyle factors significantly affect female hair loss.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Some sports supplements can cause health issues like mood swings, hair loss, and heart problems in men.